176 related articles for article (PubMed ID: 20712773)
1. Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease.
Yannaki E; Stamatoyannopoulos G
Ann N Y Acad Sci; 2010 Aug; 1202():59-63. PubMed ID: 20712773
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
Rosenbaum C; Peace D; Rich E; Van Besien K
Biol Blood Marrow Transplant; 2008 Jun; 14(6):719-23. PubMed ID: 18489998
[TBL] [Abstract][Full Text] [Related]
3. Collection of blood stem cells from patients with sickle cell anemia.
Richard RE; Siritanaratkul N; Jonlin E; Skarpidi E; Heimfeld S; Blau CA
Blood Cells Mol Dis; 2005; 35(3):384-8. PubMed ID: 16125985
[TBL] [Abstract][Full Text] [Related]
4. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
[TBL] [Abstract][Full Text] [Related]
5. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
Lebensburger J; Persons DA
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for hemoglobinopathies: are we there yet?
Puthenveetil G; Malik P
Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for homozygous beta-thalassemia. Is it a reality?
Boulad F; Rivière I; Sadelain M
Hemoglobin; 2009; 33 Suppl 1():S188-96. PubMed ID: 20001625
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
Sadelain M
Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
[TBL] [Abstract][Full Text] [Related]
9. The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in beta-thalassemia patients.
Persons DA
Ann N Y Acad Sci; 2010 Aug; 1202():69-74. PubMed ID: 20712775
[TBL] [Abstract][Full Text] [Related]
10. Management strategies for the hard-to-mobilize patient.
Stiff PJ
Bone Marrow Transplant; 1999 May; 23 Suppl 2():S29-33. PubMed ID: 10335874
[TBL] [Abstract][Full Text] [Related]
11. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
[TBL] [Abstract][Full Text] [Related]
12. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R; Murea S
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[TBL] [Abstract][Full Text] [Related]
13. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
14. Future prospects for treatment of hemoglobinopathies.
Stamatoyannopoulos JA
West J Med; 1992 Dec; 157(6):631-6. PubMed ID: 1282285
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
16. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
[TBL] [Abstract][Full Text] [Related]
17. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
Bank A
Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949
[TBL] [Abstract][Full Text] [Related]
18. Collection of hematopoietic stem cells from patients with autoimmune diseases.
Burt RK; Fassas A; Snowden J; van Laar JM; Kozak T; Wulffraat NM; Nash RA; Dunbar CE; Arnold R; Prentice G; Bingham S; Marmont AM; McSweeney PA
Bone Marrow Transplant; 2001 Jul; 28(1):1-12. PubMed ID: 11498738
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for the hemoglobin disorders.
Persons DA; Nienhuis AW
Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
Möhle R; Kanz L
Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
